Dec 05, 2016 09:54 PM
A new Centre for Research Excellence, which aims to transform diagnosis and management of severe intellectual disability (also known as neurocognitive disorders) through genomics, is to be established in Australia. The Centre is one of six clinical Centres of Research Excellence (CREs) to receive funding from the NHMRC.
Dec 05, 2016 12:32 PM
Garvan researchers have received $16 million from the National Health and Medical Research Council (NHMRC) to support their research.
Nov 29, 2016 12:52 PM
Know Your Bones, an online bone health self-assessment tool established by Garvan and Osteoporosis Australia, reached 50,000 website visits this month, and received a Highly Commended award at the prestigious National PRIA Golden Target awards.
Nov 25, 2016 05:14 PM
Paspaley recently released the “Kimberley Bracelet” to support Garvan’s cancer research. For each bracelet purchased, 25% of the purchase price is donated to a cancer research program at Garvan, with Paspaley customers choosing which area of cancer research to support.
Nov 25, 2016 04:58 PM
Garvan congratulates Dr Thomas Cox (Cancer Division), who has been awarded the JBC/Herbert Tabor Young Investigator Award at the Matrix Biology Society of Australia and New Zealand (MBSANZ) conference this week.
Nov 19, 2016 09:09 PM
Garvan’s Professor Mark Febbraio has given the Helmholtz Diabetes Centre Distinguished Lecture at the Helmholtz Zentrum München in Germany.
Nov 17, 2016 10:05 AM
DreamLab app receives a highly commended acknowledgement for the inaugural Data Innovation Award at the annual Research Australia Awards.
MEDIA RELEASE: Nov 10, 2016 09:00 PM
Australian researchers have uncovered how our immune system strikes a balance between attacking invaders and leaving our own tissues alone – and, in the process, have solved a 50-year mystery surrounding the role of an enigmatic antibody.
Nov 09, 2016 12:00 PM
The 8th Garvan Signalling Symposium, which attracts international experts to Garvan to discuss the latest advances in cell signalling research in health and disease, was held on 31 October and 1 November.
MEDIA RELEASE: Nov 08, 2016 12:00 AM
One of the highest mortality rates, no screening test and few treatment options. A breakthrough in pancreatic cancer is desperately needed.
Nov 07, 2016 12:16 PM
Garvan researchers are showing support for Movember, the “hairiest month of the year”. The funds they raise through sponsorship will go to the Movember Foundation, which works to change the face of men’s health worldwide.
Nov 04, 2016 08:00 AM
Research from Garvan and St Vincent’s Hospital has shown that whole genome sequencing has the potential to transform the diagnosis of a common inherited kidney disease.
Nov 01, 2016 11:56 AM
Fellowship means one of Australia’s brightest research talents will return from US
Oct 26, 2016 12:41 PM
The St Vincent’s Clinical Genomics Unit, which will provide genomic testing and genetic counselling to individuals with a wide variety of diseases, has today been opened by the Hon. Pru Goward MP, NSW Minister for Medical Research. The Unit has been established by St Vincent’s Hospital (Sydney) with the Garvan Institute of Medical Research.
MEDIA RELEASE: Oct 26, 2016 12:01 AM
The further a cancer patient lives from a major city, the more likely they are to die within five years of diagnosis
MEDIA RELEASE: Oct 20, 2016 12:01 PM
Action Plan Calls For National Strategy For Research Into Curing Osteoporosis And To Combat The Burden Of Fractures
Oct 19, 2016 12:00 AM
Garvan’s annual International Fellow Symposium was held for the sixteenth time on October 17th. This year, the Symposium focused on the rapidly emerging field of neurogenomics, which seeks to understand the brain and its diseases by linking genomics and neurobiology.
Oct 18, 2016 04:39 PM
Garvan’s Kinghorn Centre for Clinical Genomics (KCCG) has achieved a major milestone by sequencing its first 10,000 whole genomes since it acquired and installed its Illumina HiSeq X Ten system in 2014.
MEDIA RELEASE: Oct 14, 2016 09:35 PM
In a world first, new Australian research has revealed that genetic profiling can help predict whether an individual will break a bone through osteoporosis. The findings, which arise from Australia’s globally recognised Dubbo Osteoporosis Epidemiology Study, are likely to contribute to clinical decision-making in future, bringing us one step closer to personalised medicine for bone disease.
Sep 24, 2016 12:06 PM
Garvan is delighted to share the inspirational story of seven-year-old Alan, whose life-threatening immune disorder has been held at bay through the power of genomic information.